16.07
Immunome Inc Azioni (IMNM) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
37.22%
4.015
|
2.926 | 2.738 | 2.91 | 2.364 |
|
|
6.16%
50.49
|
47.56 | 85.71 | 53.43 | 42.37 |
| Benefits Costs and Expenses |
100.00%
-
|
44.57 | 82.99 | - | - |
| Costs And Expenses |
13.30%
50.49
|
44.57 | 82.99 | 53.43 | 42.37 |
| Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
| Operating Income/Loss |
4.13%
-46.48
|
-44.64 | -82.97 | -50.52 | -40.01 |
| Net Interest Income/Expense |
2.84%
3.081
|
2.996 | 2.721 | 3.422 | 3.887 |
| Interest Income/Expense After Provision For Losses |
2.84%
3.081
|
2.996 | 2.721 | 3.422 | 3.887 |
| Income/Loss From Continuing Operations Before Tax |
109.64%
4.015
|
-41.64 | -80.25 | 2.91 | -36.12 |
| Income/Loss From Continuing Operations After Tax |
4.22%
-43.40
|
-41.64 | -80.25 | -47.10 | -36.12 |
|
|
4.22%
-43.40
|
-41.64 | -80.25 | -47.10 | -36.12 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
9.57%
87.01
|
79.41 | 1.3998 | 60.21 | 59.94 |
| Diluted Average Shares |
9.57%
87.01
|
79.41 | 1.3998 | 60.21 | 59.94 |
| Basic Earnings Per Share |
3.85%
-0.50
|
-0.52 | -1.28 | -0.78 | -0.60 |
| Diluted Earnings Per Share |
3.85%
-0.50
|
-0.52 | -1.28 | -0.78 | -0.60 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):